title: Binding of 5H-dibenzo[a,d]cycloheptene and dibenz[b,f]oxepin analogues of clozapine to dopamine and serotonin receptors.
abstract: Series of 5,11-dicarbo- and 11-carbo-5-oxy-10-(1-alkyl-1,2,3,6-tetrahydro-4 pyridinyl) analogues and a 11-carbo-5-oxy-10-(1-methyl-4-piperidinyl) analogue of the atypical antipsychotic agent clozapine were prepared and tested for binding to the dopamine D-2L and D-4 and serotonin S-2A and S-2C receptors. Some of these analogues were found to have dopamine D-2L and D-4 and serotonin S-2A and S-2C receptor binding activities as high as or higher than those of clozapine, indicating that neither the diazepine structure nor the piperazine ring present in clozapine is essential for high antidopamine activity and or for high dopamine D-4 selectivity (Ki for the dopamine D-2L receptor/Ki for the dopamine D-4 receptor). Increasing in the effective size of the alkyl substituent at the tertiary amine nitrogen atom in the 1,2,3,6-tetrahydro-4-pyridinyl moiety in the 5H-dibenzo[a,d]cycloheptene series reduces the affinity for the dopamine D-4 receptor, but in the dibenz[b,f]oxepin series, no significant change in binding affinity to the dopamine D-4 receptor was observed. Equal or slightly higher affinity for the serotonin S-2A and S-2C receptors was observed for the 10-(1-ethyl-1,2,3,6-tetrahydro-4- pyridinyl) analogues in both series, but for the 10-[1,2,3,6-tetrahydro-1-(2-propenyl)-4- pyridinyl] analogues, any favourable steric factor is overshadowed by an unfavorable electronic effect as a result of change in the basicity of the tertiary amino group in the pyridinyl moiety. Replacement of three of the four nitrogen atoms in clozapine with three carbon or two carbon atoms and an oxygen atom and removal of the chlorine atoms gives 10-(1,2,3,6-tetrahydro-1- methyl-4-pyridinyl)dibenzo[a,d]cycloheptene and 10-(1-methyl-4-piperidinyl)dibenz[b,f]oxepin, each having twice the binding activity to the dopamine D-4 receptor as does clozapine and a dopamine D-4 selectivity equal to that of clozapine.
authors.affiliation: Department of Chemistry, Vanderbilt University, Nashville, Tennessee 37235.
authors.forename: S T
authors.initials: ST
authors.lastname: Phillips
authors.forename: T
authors.initials: T
authors.lastname: de Paulis
authors.forename: J R
authors.initials: JR
authors.lastname: Neergaard
authors.forename: B M
authors.initials: BM
authors.lastname: Baron
authors.forename: B W
authors.initials: BW
authors.lastname: Siegel
authors.forename: P
authors.initials: P
authors.lastname: Seeman
authors.forename: H H
authors.initials: HH
authors.lastname: Van Tol
authors.forename: H C
authors.initials: HC
authors.lastname: Guan
authors.forename: H E
authors.initials: HE
authors.lastname: Smith
mesh_terms: D001665:Binding Sites; D003024:Clozapine / Q000031:analogs & derivatives*; D003986:Dibenzocycloheptenes / Q000737:chemistry / Q000378:metabolism*; D003990:Dibenzoxepins / Q000737:chemistry / Q000378:metabolism*; D006801:Humans; D011954:Receptors, Dopamine / Q000378:metabolism*; D011985:Receptors, Serotonin / Q000378:metabolism*
chemical_list: D003986:Dibenzocycloheptenes; D003990:Dibenzoxepins; D011954:Receptors, Dopamine; D011985:Receptors, Serotonin; D003024:Clozapine